Biblio Discovery — Demo Discovery Service

7 results for "Jichen He"

Showing 1–7 · 0.85 seconds · RSS

  1. Journal Article

    Progress of research on PD-L1 inhibitor adebrelimab usage in malignant tumors

    Pan Cheng; Jichen He; Pingping Cheng et al.

    Frontiers in Oncology, Vol. 14 · 2024 · English · DOAJ Scopus

    Adebrelimab is a humanized monoclonal antibody against programmed death-ligand 1 (PD-L1) and is also a novel immune checkpoint inhibitor, which has been used in the first-line treatment of extensive stage small cell lung cancer (SCLC) with its unique mechanism of action and good clinical efficacy…

  2. Journal Article

    Benmelstobart+anlotinib: an emerging therapeutic option in the targeted-immunotherapy era

    Pan Cheng; Hong Gu; Qingqing Chen et al.

    Frontiers in Oncology, Vol. 16 · 2026 · English · DOAJ Scopus

    In recent years, with the gradual deepening of research, basic and clinical studies on targeted-immunotherapy combination regimens have flourished and yielded exciting results. The novel programmed cell death ligand 1 (PD-L1) inhibitor benmelstobart in combination with the targeted agent anlotinib…

  3. Journal Article

    Molecular Mechanism of MiR-136-5p Targeting NF-κB/A20 in the IL-17-Mediated Inflammatory Response after Spinal Cord Injury

    Jichen He; Jinmin Zhao; Xiaoming Peng et al.

    Cellular Physiology and Biochemistry, Vol. 44 No. 3 · 2017 · English · DOAJ Scopus

    …Western blot analysis was employed to detect protein expression. HE staining was used to assess the histological changes in SCI. The immunohistochemical staining of A20 and p-NF-κB in SCI was also analyzed. Results: The in vitro experiment showed that miR-136-5p up-regulated the expression of…

  4. Journal Article

    miR-136-5p Regulates the Inflammatory Response by Targeting the IKKβ/NF-κB/A20 Pathway After Spinal Cord Injury

    Guiying Deng; Yunbing Gao; Zhongxi Cen et al.

    Cellular Physiology and Biochemistry, Vol. 50 No. 2 · 2018 · English · DOAJ Scopus

    Background/Aims: miR-136-5p participates in recovery after spinal cord injury (SCI) via an unknown mechanism. We investigated the mechanism underlying the involvement of miR-136-5p in the inflammatory response in a rat model of SCI. Methods: Sprague-Dawley rat astrocytes were cultured in vitro to…

  5. Journal Article

    A multicenter cross-sectional study on proactive health knowledge, attitude, and practice and its influencing factors among resident standardized training physicians in Guangxi

    Qian Zeng; Jichen He; Kun Ye et al.

    Frontiers in Public Health, Vol. 14 · 2026 · English · DOAJ Scopus

    ObjectiveThe purpose of this study is to examine the state of proactive health knowledge, attitude, and practice (KAP) among Guangxi’s resident standardized training physicians as well as the factors that affect it. The results will be used to optimize health management strategies.MethodsA…

  6. Journal Article

    The Effects of miR-136-5p-Mediated Regulation of A20 in Astrocytes from Cultured Spinal Cord Cultured Cells In Vitro

    Xiaoming Peng; Xiongzhi Shi; Jinmin Zhao et al.

    Cellular Physiology and Biochemistry, Vol. 41 No. 4 · 2017 · English · DOAJ Scopus

    Background/Aims: This study focused on investigating the regulatory mechanism of miR-136-5p in mouse astrocytes stimulated with interleukin-17(IL-17). Methods: C57BL/6 mouse astrocytes were stimulated with IL-17 (100ng/ml) for various periods of time (0-48 hours) and at various doses (0-200 ng)…

  7. Journal Article

    Efficacy and safety of disitamab vedotin in treatment of advanced gastric cancer based on real-world

    Pan Cheng; Jianjuan Ge; Shuangjia Huang et al.

    Frontiers in Oncology, Vol. 16 · 2026 · English · DOAJ Scopus

    ObjectiveTo evaluate the efficacy and safety of disitamab vedotin (RC48) in the treatment of advanced gastric cancer in real-world.MethodsA retrospective analysis was conducted on clinical data of patients with human epidermal growth factor receptor 2 (HER2)-expressing advanced gastric cancer who…